Issue 8, 2019

Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro

Abstract

Organic–metal complexes are promising molecules for use in photodynamic therapy (PDT). The aim of this study was to investigate in vitro effects of novel Ru(II) and Ir(III) BODIPY complexes for PDT. These hybrid organic–metal molecules (Ru-BD and Ir-BD) have been synthesized via reactions of a BODIPY precursor (BD) with a phenanthroline unit bearing Ru(II) (3) and novel Ir(III) (4) compounds. The crystal structures of the new distyryl BODIPY (BD) and Ru(II) complex (3) are also reported. The photophysical and singlet oxygen generation properties of Ru-BD and Ir-BD were investigated in comparison with unsubstituted BODIPY (BD). Moreover, Ru-BD and Ir-BD have been biologically evaluated in vitro in chronic myeloid leukemia and cervical cancer cell lines in terms of photodynamic therapy efficacy in the presence of BD control. These complexes were not toxic in the dark but red light was needed to induce cell death. These data support the fact that Ru-BD could be accepted as a valuable photosensitizer-drug for further PDT treatment.

Graphical abstract: Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro

Supplementary files

Article information

Article type
Paper
Submitted
29 Apr 2019
Accepted
27 Jun 2019
First published
28 Jun 2019

Photochem. Photobiol. Sci., 2019,18, 2012-2022

Novel ruthenium(II) and iridium(III) BODIPY dyes: insights into their application in photodynamic therapy in vitro

N. E. Aksakal, E. Tanrıverdi Eçik, H. H. Kazan, G. Yenilmez Çiftçi and F. Yuksel, Photochem. Photobiol. Sci., 2019, 18, 2012 DOI: 10.1039/C9PP00201D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements